Senior Regulatory CMC Consultant – ADC Linker-Payload Drug Substance
6-Month Contract (Renewable) Remote – Europe
Opportunity
An exciting opportunity has arisen for an experienced Senior Regulatory CMC Consultant to support a late-stage oncology programme focused on Antibody Drug Conjugates (ADCs). This is a high-impact consultancy position where you will lead the global regulatory strategy for the linker-payload drug substance component of an innovative ADC programme as it progresses towards major regulatory submissions.
Working within a collaborative Regulatory CMC environment, you will play a critical role in ensuring that the drug substance regulatory package is submission-ready for both European and US health authorities.
This is a fully remote position within Europe offered initially as a 6-month contract with strong likelihood of extension.
Key Responsibilities
* Lead Regulatory CMC strategy for the ADC linker-payload drug substance
* Provide strategic guidance for global regulatory submissions, including FDA and EMA marketing applications
* Drive development and review of Module 3 drug substance documentation
* Ensure compliance with current ICH, FDA and EMA regulatory expectations
* Support health authority interactions and responses to regulatory questions
* Collaborate extensively with CMC, Analytical Development, Process Development, Quality and Manufacturing teams
* Contribute to regulatory risk assessments and mitigation strategies
* Provide expert advice on drug substance control strategies, specifications, characterisation and stability packages
* Support programme teams through critical development and submission milestones
Candidate Profile
Essential Experience
* Approximately 10 years or more of Regulatory CMC experience
* Strong background in drug substance development
* Proven experience leading CMC drug substance aspects of global regulatory submissions
* Deep understanding of Module 3 Quality documentation
* Excellent working knowledge of ICH, FDA and EMA regulatory requirements
* Experience supporting late-stage development or registration programmes
Highly Desirable
* Antibody Drug Conjugate (ADC) experience
* Linker-payload development experience
* Highly potent API (HPAPI) experience
* Bioconjugate or complex biologics experience
* Experience supporting Marketing Authorisation Applications (MAA), BLAs or equivalent global filings
EU Rate - €500-€600 p/day
Regulatory, CMC, ADC, drug, substance, submission, antibody, conjugate, BLA, MAA, marketing, authorisation, FDA, EMA, module
:quality(80))
:quality(80))
:quality(80))